Taken together, Xpert® Breast Cancer STRAT4 mRNA testing for ESR1, PGR, ERBB2, and MKI67 demonstrated good performance when compared to the diagnostic gold standard IHC/ISH. This evidence concerns the gene ERBB2 and breast carcinoma.